Helliwell Phillip S, FitzGerald Oliver, Fransen Jaap
From the University of Leeds, Leeds, UK, and Bradford Hospitals National Health Service (NHS) Foundation Trust, Bradford, UK; Department of Rheumatology, St. Vincent's University Hospital, Elm Park, Dublin, Ireland; Department of Rheumatology, Radboud University Medical Centre, Nijmegen, The Netherlands.P.S. Helliwell, DM, PhD, FRCP, Senior Lecturer in Rheumatology, University of Leeds and Bradford Hospitals NHS Foundation Trust; O. FitzGerald, MD, FRCPI, FRCP(UK), Newman Clinical Research Professor, Department of Rheumatology, St. Vincent's University Hospital; J. Fransen, PhD, Department of Rheumatology, Radboud University Medical Centre.
J Rheumatol. 2014 Jun;41(6):1212-7. doi: 10.3899/jrheum.140172.
There are several new composite indices for assessing disease activity in psoriatic arthritis (PsA). Each may function as a disease state variable and a responder index. The aim of our study was to determine cutoffs for disease activity and response.
Data from the Group for GRAPPA Composite Exercise (GRACE) study were used to develop cutoffs using a number of different approaches. Voting on choice of cutoff was undertaken at the 2013 GRAPPA Annual Meeting in Toronto, Ontario, Canada.
After voting, results for cutoffs for low/high disease activity for the Psoriatic ArthritiS Disease Activity Score (PASDAS), GRAppa Composite scorE (GRACE index), and Composite Psoriatic Disease Activity Index (CPDAI), respectively, were 3.2/5.4, 2.3/4.7, and 4/8. The measurement error for each composite score was estimated at 0.8, 1, and 2 for PASDAS, GRACE, and CPDAI, respectively.
Response criteria for the new composite indices have been developed. These now require further validation and testing in other datasets.
有几种新的综合指标用于评估银屑病关节炎(PsA)的疾病活动度。每种指标都可作为疾病状态变量和反应指标。我们研究的目的是确定疾病活动度和反应的界值。
来自GRAPPA综合试验(GRACE)研究的数据被用于采用多种不同方法制定界值。在加拿大安大略省多伦多市召开的2013年GRAPPA年会上对界值的选择进行了投票。
投票后,银屑病关节炎疾病活动度评分(PASDAS)、GRAPPA综合评分(GRACE指数)和银屑病综合疾病活动指数(CPDAI)的低/高疾病活动度界值结果分别为3.2/5.4、2.3/4.7和4/8。PASDAS、GRACE和CPDAI各综合评分的测量误差估计分别为0.8、1和2。
已制定了新综合指标的反应标准。这些标准现在需要在其他数据集中进一步验证和测试。